| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 55.107 | 61.770 | 62.735 | 50.334 | 59.427 | 86.634 | 84.308 | 74.837 | 92.684 | 79.159 |
| Total Income - EUR | 56.086 | 62.206 | 68.229 | 47.188 | 57.236 | 100.259 | 91.869 | 97.256 | 94.277 | 87.706 |
| Total Expenses - EUR | 45.980 | 40.848 | 47.927 | 37.060 | 39.022 | 65.802 | 57.109 | 71.635 | 62.558 | 67.267 |
| Gross Profit/Loss - EUR | 10.107 | 21.358 | 20.302 | 10.128 | 18.214 | 34.457 | 34.760 | 25.621 | 31.719 | 20.439 |
| Net Profit/Loss - EUR | 8.427 | 20.123 | 19.674 | 9.624 | 17.618 | 33.626 | 33.916 | 24.857 | 30.791 | 19.158 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Bioremed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.189 | 3.686 | 3.409 | 3.486 | 3.013 | 2.935 | 3.936 | 2.599 | 2.012 | 1.458 |
| Current Assets | 27.663 | 23.607 | 28.008 | 29.784 | 41.347 | 46.859 | 70.785 | 45.106 | 41.846 | 58.135 |
| Inventories | 7.085 | 11.851 | 15.583 | 15.284 | 9.801 | 26.536 | 27.850 | 23.159 | 18.301 | 21.882 |
| Receivables | 7.719 | 7.633 | 7.597 | 6.625 | 6.428 | 9.227 | 15.543 | 21.014 | 4.170 | 3.370 |
| Cash | 12.859 | 4.122 | 4.828 | 7.875 | 25.119 | 11.096 | 27.391 | 933 | 19.376 | 32.883 |
| Shareholders Funds | 28.343 | 21.567 | 21.093 | 30.331 | 42.303 | 34.967 | 63.054 | 26.172 | 41.337 | 56.549 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.509 | 5.726 | 10.323 | 2.939 | 2.057 | 14.826 | 3.296 | 21.534 | 2.521 | 3.043 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 8.371 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1089 - 1089" | |||||||||
| CAEN Financial Year |
1089
|
|||||||||
Comments - Bioremed S.r.l.